Volta - Volta Cohort

Volta Cohort

Helping early stage, high calibre founders attract and secure venture capital sooner

Volta Cohort provides mentorship, resources and investments of $25,000 through a fund co-founded by Volta, BDC Capital, Innovacorp, with the Atlantic Canada Opportunities Agency supporting day-to-day operations and programming. Startups interested in the program must be based in Atlantic Canada, be pre-revenue and have not yet received investment (i.e. have not closed equity financing).

Along with funding, Cohort companies are given space at Volta and access to a board of mentors comprised of CEOs and founders of Volta’s Resident and Alumni companies. The board will meet with each company every two months and hold the company accountable for agreed upon milestones and metrics. Between meetings, the companies have access to all relevant programming and support Volta provides. Dedicated programming, including workshops specific to the needs of Cohort companies are also arranged throughout the cohort year. For companies outside of Halifax, Volta will look to arrange support with partnering organizations in other cities across Atlantic Canada.

In addition to a $25,000 convertible note, Volta Cohort recipients receive the following for a one-year period:

  • Access to advisors and mentors
  • Access to Volta programming (training, workshops, events)
  • Dedicated programming specific to the needs of Volta Cohort companies
  • Space to work at Volta with meeting room access

The next Volta Cohort Pitch Event will take place on May 25, 2022. 

Register Now

The application deadline is on March 20 at 11:59pm. 

 *Volta Cohort Pitch Events take place every six months in May and November.*

Download Questions (PDF)

View Current Cohort Companies


Volta Cohort Investment

Volta Cohort recipients receive a $25 000 convertible note. After meeting program milestones, the Note will convert, and equity in the company will be obtained. Terms and conditions of the Note will be shared with the short-list of 20 companies. The 5 five recipients will undergo a full due-diligence process before funds are transferred.


Follow-On Investment

Cohort companies who have been in the program for at least six months have the opportunity to receive an additional investment of $25 000. Each year up to five cohort recipients will be selected for this additional investment. Please note, this is only available to companies participating in Volta Cohort from November 2019 onward.

To be eligible for this second round of investment, companies must meet program criteria, including active participation in the Volta Cohort Program, and be achieving established milestones (note that these are minimum requirements). The follow-on investment targets high potential, high-growth companies and additional funding is not guaranteed to all Cohort recipients. The final decision on awarding additional investment is at the discretion of the fundholders – Volta, Innovacorp, and BDC Capital.

How to Participate

Determine eligibility

Applicants must be a technology-based, early stage startup with an ambitious idea. Startups must be based in Atlantic Canada, be pre-revenue and have not yet received investment (i.e. have not closed equity financing). Founders must be coachable and looking to actively participate in Volta programs and offerings.

Submit an application

Apply before the deadline. The selection committee will consider the following: ambition of idea; disruptive level of the technology; ability of the team to execute; impact $25,000 will have on the company; and how Volta can support the growth of the company.

Apply Now

Be shortlisted

The top 20 companies will be selected and asked to virtually attend an interview with the Volta team. During this stage, applicants will also be given an overview of the term sheet, a copy of the due diligence checklist and provided with overall company expectations if selected as a recipient.

Make Top 15

From the shortlist, the top 15 companies will be selected to pitch live all in one evening for 3-minutes each. Leading up to the pitches, all participants will be given the opportunity to work with a dedicated pitch expert and will attend additional mandatory sessions to assist with preparation. A rehearsal on the day of the pitch will also be required.

Be selected as a recipient

After the pitches are complete, judges will leave the room to deliberate, selecting up to five pitch participants for the Volta Cohort Program. Winners will be announced live that evening following deliberation. 

Cohort Company Expectations

The top 15 companies are expected to attend the following sessions leading up to the pitch event:

  • Pitch Prep and Media Training 
  • Investment 101 with McInnes Cooper 
  • Investment Readiness with BDO 
  • Volta Quarterly Pitch Competition (optional)
  • Volta Cohort Rehearsal

Once selected as a Cohort recipient, companies are expected to:

  • Submit bi-monthly company updates and attend check-in meetings
  • Attend Volta Cohort required training sessions
  • Complete the due diligence process within 6 months
  • Innovacorp

Current Cohort Companies

Amp Health

Focus: Health

Amp Health is on a mission to prevent 10 million people from developing chronic disease in the next 10 years. Their first product, Struggle app, uses unique behaviour change techniques and machine learning to help prevent diabetes in prediabetics. 


Focus: Risk Management Software

DependBuild helps municipalities and infrastructure developers identify, assess, and track their risks with their cloud-based risk management software solution.

Easy Platter

Focus: Online Food Services Platform

Easy Platter is a platform that connects you with a local chef for your weekly, in-home meal prep.

HOLLO Medical

Focus: Health

HOLLO Medical is developing the next generation of holding chambers for inhaler users.

MOC Biotechnologies Inc.

Focus: Health

MOC Biotechnologies Inc offers hybrid bioprinting technologies to clone hard and soft implants, scaffolds, tissues and organs to deliver world-class solutions for pharmaceutical companies, research centres, universities, laboratories and institutes.

Myomar Molecular Inc.

Focus: Health

Myomar Molecular Inc is developing a diagnostic tool to detect muscle loss.


Focus: Health

Parados provides members of high-performance athletics and military organizations with the tools needed to reach and maintain their cognitive potential.


Focus: Health

PragmaClin is transforming neurological disease monitoring, by using innovative digital tools to manage movement disorder assessments from home.